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Abstract.  The membrane-spanning  and cytoplasmic 
domains of CD4 and CD8 were replaced by those of 
TGN38. After transient expression in HeLa cells, the 
location of the hybrid proteins was determined using 
immunofluorescence and quantitative immuno-electron 
microscopy, FACS analysis and metabolic labeling. 
The membrane-spanning  domain was found to contain 
a  signal that localized hybrid proteins to the TGN. 
This was in addition to the signal previously identified 
in the cytoplasmic domain (Bos, K.,  C.  Wraight,  and 
K.  Stanley.  1993.  EMBO (Eur.  Mol.  Biol.  Organ) J. 
12:2219-2228.  Humphrey, J.  S., P. J.  Peters,  L.  C. 
Yuan, and J.  S. Bonifacino.  1993. J.  Cell Biol. 
120:1123-1135.  Wong,  S. H., and W.  Hong.  1993. J. 
Biol.  Chem.  268:22853-22862).  The different proper- 
ties of these two signals suggest that each operates by 
a different mechanism. 
p 
ROTEINS synthesized  in the ER are funneled  through 
the Golgi apparatus for further processing and sorting 
(for review see Kornfeld,  1992; Mellman and Simons, 
1992;  Rothman  and Orci,  1992).  Proteins  first  enter the 
tubulo-vesicular  cis-Golgi network and progress through the 
stack comprising cis-, medial-, and trans-cisternae  until they 
reach the tubulo-vesicular  TGN (Rambourg and Clermont, 
1990). The final stages of N-linked oligosaccharide process- 
ing occur in the TGN (Roth et al.,  1985; Grifliths  and Si- 
mons, 1986; Cooper et al., 1990; Griffiths et al., 1989), and 
proteins are sorted to their correct destination  (Griffiths and 
Simons,  1986; Peters et al.,  1991; Kornfeld,  1992). Along 
the exocytic pathway as far as the TGN, consecutive steps in 
protein  transport  appear  to be mediated by non-clathrin- 
coated vesicles (for review see Rothman  and Orci,  1992). 
Transport occurs by default, provided the proteins have been 
correctly folded in the ER (Gething and Sambrook,  1992). 
In contrast,  resident ER and Golgi proteins are retained in 
specific compartments,  raising  questions as to the mecha- 
nism by which this occurs. 
Resident proteins are localized by retention  or retrieval 
signals  (for review see Pelham,  1989;  Machamer,  1991; 
Kornfeld,  1992;  Nilsson et al.,  1993b).  Retrieval  signals 
have been found on both soluble and membrane bound pro- 
teins of the ER (Munro and pelham,  1987; Nilsson et al., 
1989; Jackson et al.,  1990).  The carboxy-terminal  KDEL 
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motif results in the retrieval of soluble ER proteins lost from 
this  compartment  (Munro  and  Pelham,  1987).  This  se- 
quence is recognized by a receptor which returns the protein 
to the ER (Semenza et al., 1990; Lewis and Pelham,  1992). 
Some membrane proteins contain a double-lysine motif in 
the cytoplasmic tail which ensures retrieval to the ER (Jack- 
son et al.,  1993). 
Golgi retention  signals were first identified in a viral pro- 
tein (Swift and Machamer,  1991) and in Golgi glycosylation 
enzymes (Nilsson et al.,  1991; Munro,  1991; Aoki et al., 
1992; Burke et al.,  1992; Colley et al.,  1992; Tang et al., 
1992; Teasdale et al., 1992; Wong et al., 1992). In all cases, 
the retention  signal lies in the membrane-spanning  domain. 
More recently, membrane-spanning  domains have been im- 
plicated in the localization  of two proteins to the nuclear 
envelope  (Wozniak  and  Blobel,  1992;  Smith  and  Blobel, 
1993). 
So far, none of the proteins studied have been shown to 
contain both a retention  and a retrieval  signal though  there 
are indications  that more than one signal is present in some 
of them.  When the carboxy-terminal  -KDEL signal  is re- 
moved  from the  soluble BiP protein,  it is  secreted very 
slowly (Munro and Pelham,  1987). When the double-lysine 
motif is removed from glucuronosyltransferase,  an integral 
membrane protein,  little if any escapes from the ER (Jackson 
et al., 1993). Both these cases suggests that a retention signal 
is present in addition  to the retrieval  signal. 
To determine whether a protein can contain both signals, 
we focused on TGN38, a resident of the trans-Golgi  network 
(Luzio et al.,  1990). TGN38 has a tyrosine-based motif in 
the cytoplasmic domain that acts as a retrieval signal, return- 
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1993; Humphrey et al., 1993; Wong and Hong, 1993). Here 
we have looked for the second signal and have found it in the 
membrane-spanning  domain. 
Materials and Methods 
Materials 
Chemicals and reagents were obtained from the sources described by Nils- 
son et al. (1993a, 1994). Restriction enzymes, T4 DNA ligase, and poly- 
nucleotide kinase for recombinant DNA procedures were purchased from 
GIBCO BRL (Gaithershurg, MD), New England Biolahs (Bethesda, MD), 
or Pharmacia Corp. (Uppsala, Sweden). Sequencing reagents and T7 poly- 
merase were purchased from USB Biochemicals. Cell culture media, fetal 
calf  serum, amino acids,  and penicillin/streptomycin  were from GIBCO 
BRL. [3sS]Mcthionine/cystcine  in  vivo  labeling  mix was from Amersham 
Corp. (Amersham, UK). Chemicals were purchased from Sigma Chem. 
Co. (St.  Louis,  MO), BDH  (Poole,  UK), or Fisons  Inc.  (UK). 
Recombinant DNA Procedures 
The TGN38 eDNA (Lnzio et al., 1990) was mutagenized by PCR such that 
a BamHI site was introduced just after the stop codon. The HindIII-BamHI 
fragment containing the 5' untranslated region and the complete coding se- 
quence was cloned between the same restriction sites in the pCMUIV plas- 
mid (Nilsson et al., 1989). The TGN38 eDNA in the mammalian expres- 
sion vector pUEX (Luzio et al.,  1990) was used as a template for PCR 
amplification under the conditions described by Salki et al.  (1988). 
Oligonucleotides used in PCR reactions were generally synthesized with 
BamHI flanking sequences to facilitate easy cloning into plasmid vectors 
for sequencing. Oligonucleotides were used at  I  mM in PCR reactions. 
PCR products were ethanol precipitated, digested with BamHI, and cloned 
into the pBS plasmid (Stratagene Corp., La Jolla,  CA) for sequencing. 
DNA  sequencing  was carried  out using the dideoxy  chain  termination 
method and T7 polymerase (Tabor and Richardson, 1987). Plasmid deriva- 
fives were digested with the appropriate enzymes to generate the correct 5' 
and 3' ends for cloning and construction of CD8 and CD4 eDNA chimeras. 
CD8 hybrid proteins were constructed such that the first 153 amino acids 
of the extracellular domain of c~CD8 were preserved. This is sufficient for 
CD8 glycosylation and secretion (~y  et al., 1992), and should also not 
affect the ability of  CD8 hybrid proteins to form homodimers (Leahy et al., 
1992; Boursier et al., 1993). PCR-generated DNA fragments were cloned 
into the pCMUIV expression vector (Nilsson et al., 1989) using 3 DNA 
fragments in a llgation. To construct the CD8-MC and CD8-MAC chimeric 
cDNAs the llgation mix contained (1) the HindHI-ApaLI  DNA fragment 
that encoded most of the lumenal domain of the CD8 molecule,  (2) an 
ApaLI-BamHI  DNA fragment that encoded the membrane-spanning and 
cytoplasmic domain sequences of TGN38, and (3) the pCMUIV vector as 
a HindIlI-BamHI  DNA fragment. 
To construct the CDS-M membrane-spanning chimeric eDNA the liga- 
tion contained (1) the HindllI-ApaLI DNA fragment that encoded most of 
the lumenal domain of the CD8 molecule, (2) an ApaLI-SalI  DNA frag- 
ment that contained the membrane-spanning domain of  TGN38, and (3) the 
pCMUIV plasmid vector as a HindIII-SalI DNA fragment which also con- 
talned the cytoplasmic domain of the CD8 molecule. 
To construct the CD8-C and CD8-AC chimeric cDNAs the ligation con- 
tained (1) a SalI-BamHI DNA fragment that contained the cytoplasmic do- 
main of TGN38, and (2) the pCMUIV vector as a BamI-II-SalI DNA frag- 
ment which also contained the lumenal and membrane-spanning domains 
of the CD8 molecule. 
Cloning of  the CD4 eDNA into the pCMUIV plasmid has been described 
by Nilsson et al. (1989) and we used this CD4 plasmid initially. However, 
there were no unique restriction sites in the CD4 eDNA at equivalent posi- 
tions  which  would  have  allowed us  to  insert  replacement  membrane- 
spanning and cytoplasmic TGN38 sequences. We thus inserted unique re- 
striction sites within the CD4 eDNA using PCR mutngenesis. Deen et al. 
(1988) have shown that a CD4 molecule terminating after residue 371 in the 
extracellular domain is efficiently secreted. As the threonine at 369 is fol- 
lowed by a proline residue, this would make it unlikely that there are any 
structural features after thr-369 necessary for correct folding and transport 
of CD4. Codon 367 (Maddon et al., 1985) in the CD4 eDNA (which en- 
codes a serine residue) was mutated from TCC to TCA. This silent mutation 
created a single HincII site within the CD4 eDNA. Similarly, codons 400 
and 401 (encoding arginine residues) were mutated from CGA AGG to CGT 
CGA. These silent mutations created a unique SalI site in the CD4 eDNA. 
There were now unique restriction sites on either side of the membrane- 
spanning region in the eDNA. PCR was carried out on the TGN38 eDNA 
using ollgonucleotides similar  to those described  above. Instead of the 
ApaLI site used in CD8 chimera constructions, 5' oligonucleotides that pre- 
cede the TGN38 membrane-spanning  domain were synthesized  with a HincH 
site. A HincH-SalI or HincH-BamHI DNA fragment containing TGN38 se- 
quences could be fused to CD4 by ligation as described previously. We 
thus ligated either a HindlII-HincII or HindIII-SalI DNA fragment (encod- 
ing the lumenal domain of the CD4 molecule) from pCMUIV-CD4, an ap- 
propriate PCR generated DNA fragment that encoded TGN38 sequences, 
and an appropriate pCMUIV vector. Ligations were transformed into E. 
coil strain JM101 using standard procedures (Sambrook et al., 1989) and 
clones were analyzed by restriction digestion followed by DNA sequencing. 
Large-scale preparations of  the pCMUIV plasmids (for transfections) were 
made by alkaline lysis followed by CsCl-ethidium  bromide  purification 
(Sambrook et al., 1989). 
Cell Culture and Transfections 
Monolayer  HeLa  cells  (ATCC CCL185)  were  grown  in  DMEM  sup- 
plemented with 10% FCS, non-essential amino acids, penicillin/streptomy- 
cin, and 2 mM glutamine. Cells were grown to 20-30% conttuency before 
transfection by the calcium phosphate method essentially as described by 
Nilsson et al. (1989). For immunottuorescence, cells were seeded out into 
30-ram,  6-weil plates  (Becton Dickinson,  Lincoln Park,  NJ) containing 
sterile coverslips. After one day, cells were transfected with 2 ~g of  plasmid 
DNA (CsCI-EtBr purified) and 3/tg of  pUC19 plasmid DNA (used as a car- 
rier to increase transfection efficiency). Cells were fixed and processed for 
immunottuorescence 60-72  h later (Nilsson et al.,  1989; Jackson et al., 
1990). Transfected cells for electron microscopy and immunoprecipitation 
were prepared as described by Nilsson et al. (1989) in 100-mm tissue cul- 
ture dishes and processed 60-72  h after DNA was added. 
Indirect Immunofluorescence  Microscopy 
Cells were processed for immunofluorescence microscopy as described pre- 
viously (Warren et al., 1984; Nilsson et al., 1991). The rabbit antiserum 
to TGN38 has been described by Luzio et al. (1990) and was diluted (1:500) 
in 0.2% fish skin gelatin/PBS before use. GaIT was detected using either 
a  rabbit  polyclonal  antiserum  (Roth and  Berger,  1982; Nilsson  et al., 
1993a) at a dilution of 1:200 or the monoclonal antibody GT-2 (Berger et 
al., 1986). Culture supernatants from the QS4120 (Healey et al., 1990) and 
OKT8 (ATCC CRL 8014) mouse bybridomas were used to detect CD4 and 
CDS, respectively. The secondary antibodies were horse anti=mouse con- 
jngated to Texas red (Vector Labs, Burlingame, CA) and sheep anti-rabbit 
conjugated to FITC (Dakopatts, Copenhagen) and both were used at a dilu- 
tion of 1:100. P-,hodamine-conjngated  transferrin  (Molecular Probes,  Eu- 
gene, OR) was dissolved in PBS and used at a final concentration of 20 
~tg/ml; ceils were incubated in fresh media containing the ligand for 30 rain 
at 37°C before washing with PBS and fixation. Slides were examined on a 
Zeiss Axiophot fluorescence microscope using a 63)< objective oil immer- 
sion lens and a  10)< eyepiece. 
Electron Microscopy and Stereological  Analysis 
Transfected cells were fixed in 2 % paraformaldehyde/0.2  % glutaraldehyde 
in 0.1 M phosphate buffer pH 7.4 for 3 h and processed for cryo-immuno- 
electron microscopy essentially as described by Rabouille et al. (1993). Cell 
pellets embedded in gelatin were cut into blocks and infused with 2.3 M 
sucrose overnight. The blocks were frozen in liquid nitrogen, ultrathin cryo- 
sections were cut and incubated for 30 rain with primary antibodies. Poly- 
clonal rabbit antiserum to TGN38 (Lnzio et al., 1990) was used at a dilution 
of 1:100 and an affinity-purified rabbit antibody to CD4 (Dr. Mark Marsh, 
MRC Centre, University College London) at a dilution of 1:100. Both were 
diluted into 0.5% fish skin golatin/PBS and the bound antibodies were de- 
tected using protein A-coupled to 10-nm gold particles used at a dilution 
of 1:50 (from  Cell  Biology Department,  Ultrecht School of Medicine, 
Utrecht,  Netherlands).  The monoclonal  antibody  14  to CD8  (Haynes, 
1986) was used neat as a culture supernatant and bound antibodies were de- 
tected using a secondary goat anti-mouse antibody coupled to 10-rim gold 
particles at a dilution of 1:20 (Nilsson et al., 1994). Immunolabeling was 
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as described by Tokuyasu (1980). 
Quantitation of immunolabeling was carried out by first identifying a la- 
beled area of the cell where profiles of the Crolgi stack and TGN were readily 
visible. The TGN was defined morphologically  as described in the Results. 
Labeled cell sections were placed in one of two categories.  Cell sections 
in which no eodosomes were labeled consistently contained fewer  than 
50-60 gold particles whereas cell sections containing labeled endosomes 
contained more than 50-60 gold particles.  In each experiment, 200-1,000 
gold particles were counted depending on the type of construct used for 
transfection (see Fig. 6 legend).  The background observed in each experi- 
ment was extremely low and therefore ignored. 
The relative distribution of immunolabeling was performed by counting 
the gold particles over the membranes (Golgi stack, TGN, endosornes,  and 
plasma membrane) of selected cells. The linear density of the gold particles 
at the plasma membrane was estimated by the point hit method. Briefly, pic- 
tures were printed at 38,750×  or 52,000× final magnification and overlaid 
with a grid containing a point-to-point spacing of 2 crn (plasma membrane) 
or 0.5 cm (TGN) (d). The number of intersections (I) of the membrane with 
this grid were counted.  The total number of gold particles over the total 
membrane was counted and the linear density was then calculated using the 
formula:- Gold particles/(I X d/magnification). 
FACS Analysis 
Transfected cells were grown in 30-ram wells and processed for FACS anal- 
ysis exactly as described by Nilsson et al. (1989).  Native and hybrid CD8 
proteins were detected using the culture supernatant from the OKT8 hybrid- 
oma. Approximately 5  ×  105 cells were incubated with the primary anti- 
bodies on ice for 20 rain followed by gentle washing.  The secondary anti- 
body was FITC-conjugated  sheep anti-mouse (Vector Labs., Burlingame, 
CA) used at a  dilution of 1:100. After washing,  cells were fixed in 3% 
paraformaldehyde/PBS  for 20 rain on ice. Immediately before FACS analy- 
sis, cells were washed three times with calcium/magnesium-free PBS and 
resuspended in 0.5 ml of this solution. A Becton-Dickinson FACScan 440 
machine was used to analyze the samples.  Quantitation of FAnS data was 
performed by calculating  two parameters: the amount of positive cells ex- 
pressing each protein and the arithmetic mean intensity of fluorescence  of 
these positive cells (~:Ni.Ii2/~Nili).  The mean intensity was multiplied by 
the number of positive cells which gave the total fluorescence intensity (ar- 
bitrary units) detected for the positive cell population. The total fluores- 
cence intensity of the CD8 positive cells was represented as 100% and the 
total fluorescence  intensity of positively gated cells expressing  other CD8 
hybrid proteins were expressed  as a percentage of total CD8. 
lmmunoprecipitation  of  Hybrid Proteins 
Immunopreeipitation was carried out essentially as described by Jackson et 
al. (1989). Transfected cells in 100-mm dishes were labeled with 0.2 rnCi 
[35S]methionine/cysteine for 20 rain and either lysed in detergent immedi- 
ately or chased with medium containing excess cold methionine and cys- 
teine. After 15 rain on ice the cells were scraped off and lysates centrifuged 
at medium (12,000 g,  10 min at 4°C) and high speed (400000 g, 30 rain 
at 40C) to remove particulate material. The supernatants were precleared 
by incubation with mouse IgG bound to protein A-Sepharose  (Pharmacia 
Corp.,  Uppsala, Sweden)  and native and hybrid proteins were immuno- 
precipitated using QS4120 (anti-CD4) or OKT8 (anti-CDS) antibody bound 
to protein A-Sepharose.  Immunoprecipitates were then washed sequentially 
twice with lysis buffer, once with lysis buffer containing 0.1% SDS, once 
with lysis buffer containing 0.5 M NaCI, twice with lysis buffer, and finally 
once with low ionic strength buffer (20 rnM Tris pH 7.5, 0.1% TX-100). Af- 
ter the final  wash,  immunoprecipitates were divided equally and resus- 
pended in 15 #1 of neuraminidase digestion buffer (300 mM NaC1, 100 ram 
sodium acetate pH 5.5, 14 mM calcium chloride and I mM PMSF) contain- 
ing either 25 mU neuraminidase (Type VIII; Sigma) or buffer (mock treat- 
ment). Samples  were incubated at 37"C for 4 h before analysis by SDS- 
PAGE and fluorography. 
Results 
CD8 and CD4 Hybrid Proteins 
We have used both CD8 and CIM as the reporter molecules. 
These glycoproteins are members of the Ig superfamily and 
are  normally expressed  on the surface  of T-lymphocytes 
(Littman  et al.,  1985; Maddon et al.,  1985). The ~CD8 
polypeptide  consists  of 214  amino  acids  (Littman  et ai., 
1985) and CD4 of 435 residues (Maddon et al., 1985). The 
amino acid sequences of the membrane-spanning and cyto- 
plasmic domains of CD8 and CD4 are shown in Fig.  1 A. 
Rat TGN38 is a type I glycoprotein with a predicted molecu- 
lar weight of 38 kD but glycosylation increases this to 85-95 
kD (Luzio et al., 1990). Signal peptide cleavage produces a 
mature protein of 340 residues. The large lumenal domain 
(residues 1-287) is followed by a single membrane-spanning 
domain (residues 288-306)  and a short cytoplasmic domain 
(residues 307-340;  see Fig.  I A). 
Chimeric cDNAs were constructed by replacing domains 
in CD4 and CD8 with those in TGN38 at identical amino 
acids in the three proteins (see Fig. 1 A). This meant that hy- 
brid proteins containing the membrane-spanning domain of 
TGN38 also  included  some of the flanking amino  acids. 
Flanking sequences have been shown to influence substan- 
tiaily the ability of membrane-spanning domains to localize 
proteins to the Golgi apparatus (Nilsson et al., 1991; Munro, 
1991; Colley et al.,  1992). 
Immunofluorescence Microscopy of CD8 and CD4 
Hybrid Proteins 
Rat TGN38 eDNA (Luzio et al., 1990) was cloned into the 
pCMUIV  expression  vector  (see Materials  and Methods) 
and the plasmid introduced into cells by calcium phosphate 
transfection. At 72 h after transfection, immunofluorescence 
microscopy  showed that TGN38 was localized  to a jux- 
tanuclear reticulum (Fig. 2 A) very similar to that stained by 
antibodies to GaIT (Fig. 2 B), a resident of the trans-Golgi 
cisterna  (Roth and Berger, 1982) and the TGN (Lucocq et 
al., 1989; Taatjes et ai., 1992; Nilsson et al., 1993a). Higher 
levels of TGN38 led to an accumulation of the protein  in 
punctate structures in the cytoplasm (Fig. 2 A) and at the cell 
surface (data not shown; see later). These data are consistent 
with the localization of endogenous TGN38 in NRK cells 
and expressed protein in transfected CV-1 cells (Luzio et al., 
1990). 
The  membrane-spanning  (M)  and cytoplasmic  (C)  do- 
mains of TGN38 were grafted on to the lumenal domain of 
CD8 (see Fig. 1 B). CD8 was mostly present on the cell sur- 
face though a small amount was present in small punctate 
structures, especially at high levels of  expression (Fig. 2 C). 
The hybrid protein (CD8-MC), however, was restricted to a 
compact juxtanuclear reticulum  (Fig.  2 D)  that was very 
similar  to  that  stained  by  antibodies  to  GaIT  (data  not 
shown). The membrane-spanning and cytoplasmic domains 
of TGN38 were also grafted on to the lumenal domain of 
CD4. Transiently expressed CD4 was mostly localized to the 
plasma membrane (Fig. 2 E), but the CD4-MC hybrid pro- 
tein was again localized to a juxtanuclear compartment (Fig. 
2 F), very similar to that stained by antibodies to GaIT (data 
not shown). There was also faint staining of  the nuclear enve- 
lope, suggesting some accumulation of both hybrid proteins 
within the ER (arrows in Fig. 2, D and F). 
To show that the membrane-spanning and cytoplasmic do- 
mains of  TGN38 contained distinct localization signals, each 
of  these domains in both CIM and CD8 was replaced by that 
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the  membrane-spanning (un- 
derlined)  and  cytoplasmic 
domains  of CD8, CD4,  and 
TGN38. The membrane-span- 
ning domain of CIM  is that 
defined  by  Maddon  et  al. 
(1985) although it could  in- 
elude an additional two amino 
acids (-CV-) on the cytoplas- 
mic  side  of the  membrane. 
Amino acid residues at which 
domains were replaced in the 
different hybrid  proteins  are 
numbered.  (B  and  C)  Line 
sketches show CDS, CIM, and 
hybrid proteins  containing the 
membrane-spanning  and  cy- 
toplasmic domains of TGN38 
(shaded and boxed). Hybrid 
proteins  are  defined by  suf- 
fixes  which  denote the domains 
of CD8 or CD4 that were re- 
placed by equivalent domains 
of TGN38. M  =  membrane- 
spanning domain and flanking 
residues;  C  =  cytoplasmic 
domain; and AC =  truncated 
cytoplasmic  domain  lacking 
21 residues from the carboxy- 
terminus. 
in  TGN38  (Fig.  1,  B  and  C).  The  TGN38  membrane- 
spanning domain alone localized the hybrid proteins to the 
Golgi apparatus. Both CD8-M (Fig. 3 A) and CD4-M (Fig. 
3 E) gave a discrete juxtanuclear staining pattern very simi- 
lar to that for GAIT, especially at low levels of expression 
(Fig. 3, B and F,, respectively). At higher levels of  expression, 
staining was more diffuse suggesting accumulation in vesi- 
cles and at the cell surface (data not shown). This pattern was 
more frequently observed for CD4-M than for CDS-M. 
The  cytoplasmic domain  of TGN38  contained,  as  ex- 
pected, the other Golgi localization signal (Bos et al., 1993; 
Humphrey  et  al.,  1993;  Wong  and  Hong,  1993).  Both 
CD8-C (Fig. 3 C) and CIM-C (Fig. 3 G) were detected in 
a  juxtanuelear  reticulum very  similar  to  that  containing 
GaIT (Fig. 3, D and H, respectively). At all levels of expres- 
sion staining of small punctate structures (Fig. 3, C and G) 
was also observed and these were shown to be endosomes 
by immunoelectron microscopy (see below). 
Immunofluorescence Microscopy of CD8 
Hybrid Proteins Containing a Truncated TGN38 
Cytoplasmic  Domain 
Replacing the membrane-spanning domain of either CIM or 
CD8 with that of TGN38 could have activated or corrupted 
a localization signal in the cytoplasmic domain of the hybrid 
proteins. CD8 has a tyrosine residue in the cytoplasmic do- 
main but it is the penultimate amino acid that would not nor- 
really be expected to operate as a retrieval signal (Fig. 1 A). 
CD4 contains a  signal for endocytosis (Shin et al.,  1990, 
1991) but this does not normally direct the protein to the 
TGN. Nevertheless, to eliminate the possibility of activating 
The Journal of Cell Biology,  Volume 125, 1994  256 Figure 2. lmmunofluorescence microscopy on transfected HeLa cells expressing either TGN38 (A and B), CD8 (C), CD8-MC (D), CIM 
(E), or CEB-MC (F). Cells were fixed, permeabilized, and either double-labeled  with polyclonal  antibodies to TGN38 (A) and a monoclo- 
nal antibody GT-2 to GaIT (B), or stained with the monoclonal antibody OKT8 to CD8 (C and D), or the monoclonal antibody QS4120 
to CD4 (E and F). Arrows in D and Findicate stainin  s of the nuclear envelope. Bound antibody was visualized using secondary antibody 
coupled to FITC (A) or Texas red (B-F). Magnification 800x. 
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copy on transfected HeLa cells express- 
ing either CDS-M (,4 and B), CDS-C (C 
and D), CD4-M (E and F), or CIM-C 
(G and H). Cells were fixed, permeabi- 
lized,  and  double-labeled  with  either 
OKT8 to CD8 (A and C) or QS4120 to 
CD4 (E and G) and polyclonai antibod- 
ies to GaIT (B, D, F, and H). Bound anti- 
body was visualized using secondary an- 
tibody coupled to Texas red (,4, C, E, 
and G) or FITC (B, D, F, and H). Ar- 
rows inF show staining for GaIT in non- 
transfected cells. Magnification 800x. 
or corrupting a cytoplasmic signal, we exploited the fact that 
the localization signal in the cytoplasmic domain of TGN38 
has been mapped to the sequence,  SDYQRL (Bos et al., 
1993; Humphrey et al., 1993; Wong and Hong, 1993). Com- 
parison of the hybrid protein CD8-MC (Fig. 4 A) with CD8- 
MAC (Fig. 4 B), which lacked this sequence, showed that 
it had no significant effect on the localization of the protein 
to the Golgi apparatus. Both were localized to a juxtanuclear 
reticulum very similar to that stained by antibodies to GaIT 
(data not shown). Expression of the CD4-MAC hybrid pro- 
tein gave similar results (Fig. 4 E). 
To show that we had in fact eliminated the localization sig- 
nal in the cytoplasmic domain of TGN38, we expressed a 
CD8 or CD4 hybrid protein containing the truncated cyto- 
plasmic domain from TGN38 (CD8-AC or CD4-~C; Fig. 1 
B). Unlike CD8-C (see Fig. 3 C), the CD8-AC hybrid pro- 
tein was not in the Golgi apparatus but exhibited a cell sur- 
face staining pattern and additional accumulation in intracel- 
The  Journal  of  Cell  Biology,  Volume 125,  1994  258 Figure 4.  Immunofluorescence microscopy on transfected HeLa ceils expressing either CD8-MC (,4), CD8-MAC (B), CD8-AC (C and 
D), CIM-MAC (E), or CIM-AC (F). Cells were fixed, permeabilized, and stained with OKT8 to CD8 (A-C) or QS4120 to CIM (E and 
F). Bound antibody was visualized using secondary antibody coupled to Texas red (A, B, E, and F) or FITC (C). D shows the staining 
pattern for rhodamine-labeled transferrin after incubation with cells for 30 min. Arrowheads in C and D indicate structures containing 
both CDS-AC and transferrin. Magnification 800×. 
Pormambalarn et al. Localization Signals in TGN38  259 Figure 5. Immunolabeling for TGN38, CD8, and CD4 hybrid proteins in transfected cells. Cryosections of HeLa cells expressing either 
TGN38 (A), CDg-MC (B), CDS-M (C), CD4-MC (D), CD4-C (E), or CD4-M (F) were immunolabeled with either polyclonal  antibodies 
against TGN38 (A); monoclonal antibody 14 to CD8 (B and C); or polyclonal  antibodies to CD4 (D-F). Polyclonal antibodies were detected 
using protein A-conjugated to 10-nm gold (A, D-F) or secondary antibodies (B and C) conjugated to  10-nm  gold particles. The TGN 
(T) was labeled in all cells and the Golgi stack (G) to a much lesser extent. Cells expressing CD4-M (F) and CD4-C (E) were pretreated 
for 2 h with 10/~g/ml cycloheximide. Note that higher levels of expression of TGN38 (A) and CD4-M (F) led to labeling of endosomes 
(E) and the plasma membrane (PM). Bar, 0.2/~m. Figut~ 5. Table L Immunolabeling of TGN38, CD4-M, and CD4-C Hybrid Proteins in the TGN, Endosomes, and Plasma Membrane 
Relative distribution over membranes  (%)  Linear density (gold particles/t,m)* 
Gold particles/  Golgi  Plasma  Plasma 
cell section*  apparatus  Endosome  membrane  TGN  membrane 
TGN38  <60  100  0  0  2.57  +  1.0  0 
TGN38  >60  60 -4- 7  29 +  7  11  5- 7  3.44 5- 0.8  0.81  5- 0.5 
CIM-M  <50  100  0  0  0.74  + 0.4  0 
CD4-M  >50  61  +  8  35  5- 8  4 5- 3  1.78 5- 0.6  0.15  5- 0.12 
CD4-C  <55  55.4 5-  17  35  5-  17  9.6  +  6  0.73  5- 0.2  0.08  5- 0.05 
CD4-C  >55  39.3  5-  15  59.5 5-  15  1.2  5- 0.6  1.92 5- 0.8  0.08  5- 0.05 
* The two categories  of transfected  cells, low "expressers"  (<) and high "expressers  ~ (>), were  defined as described in Materials and Methods. The total number 
of gold particles counted was 1695 CrGN38), 1036 (CD4-M), and 1302 (CD4-C). 
* The linear density at the plasma membrane  and in the TGN was estimated for the expressed  proteins as described in Materials and Methods. The number  of 
gold particles  counted as the plasma  membrane  was 300 (TGN38), 70 (CIM-M),  and 60 (CD4-C). Note  that for TGN38 and CIM-M, gold  labeling at the plasma 
membrane correlated  with labeling of endosomes. 
lular punctate  structures  (Fig.  4  C).  Some of these were 
shown to be early endosomes (arrowheads in Fig. 4, C and 
D)  by preincubating  the  cells with  rhodamine-conjugated 
transferrin for 30 min before fixation and processing. CD4- 
AC was found to be expressed largely on the cell surface of 
transfected cells (Fig. 4  F). 
lmraunoelectron  Microscopy of CD8 and CD4 
Hybrid Proteins 
To determine the precise location  of the  hybrid proteins, 
cryosections of transfected cells were labeled with antibodies 
which were detected by appropriate gold conjugates.  The 
TGN is defined morphologically as a  tubulo-reticular net- 
work, part of which is closely apposed to the trans side of 
the  Golgi  stack.  Budding  and  vesicle profiles  coated by 
clathrin are often observed (Orci et al., 1984, 1985; Griffiths 
and Simons, 1986). Transiently expressed TGN38 was found 
in the TGN, the Golgi stack,  endosomes, and the plasma 
membrane (Fig. 5 A). The distribution of TGN38 depended 
on the level of expression.  At low levels (<60 gold parti- 
cles/cell section) TGN38 was found exclusively in the Golgi 
apparatus (Table I) with most of  the protein (85 +  7%) being 
found in the TGN (Fig. 6). None was detected in either endo- 
somes or on the plasma membrane (Table I). At higher levels 
of expression (>60 gold particles/cell section) the percent- 
age of labeling over the Golgi apparatus fell (to 60  5:7 %) 
and rose over endosomes (to 29 5:7 %) and the plasma mem- 
brane (to 11  +  7%) (Table I). Even at high levels of expres- 
sion the linear density of labeling over the TGN was four 
times that over the plasma membrane showing that the pro- 
tein was still concentrated in the TGN. 
Hybrid proteins containing both localization signals gave 
patterns of labeling almost indistinguishable  from TGN38 
both  morphologically  and  quantitatively.  Both  CD8-MC 
(Fig. 5 B) and CD4-MC (Fig. 5 D) were present only in the 
Golgi apparatus at all levels of expression and more than 
80 % of the label was present in the TGN (Fig.  6). 
Hybrid proteins containing only the membrane-spanning 
domain also gave results very similar to those for TGN38. 
CD4-M was present only in the Golgi apparatus at low levels 
of expression (<50 gold particles/cell section; Table I) with 
80 5:8 % being present in the TGN (Fig. 6). At higher levels 
of expression (>50 gold particles/cell section) the percentage 
of total labeling over the Golgi apparatus fell (to 61  5: 8%) 
and rose over endosomes (to 35  +  8%) and plasma mem- 
brane  (to  4  +  3%)  (Table  I).  This  distribution  was  not 
affected by pretreatment of the cells for 2 h with cyclohexi- 
mide (Fig. 5 F). The linear density of labeling over the TGN 
was 11  times that over the plasma membrane, even higher 
than that for TGN38  (Table I).  The other hybrid protein, 
CDS-M, was also present exclusively in the Golgi apparatus 
(Fig. 5 C) and most (66 5: 8%) was present in the TGN (Fig. 
6).  However, more of the protein was present in the Golgi 
stack than for other hybrid proteins. We also examined cells 
expressing CD4-M after incubation in cycloheximide for 7 
h and found no significant change in the pattern of labeling 
(data not shown). 
The CD4 hybrid protein containing the cytoplasmic do- 
main (CD4-C) was also localized using immunoelectron mi- 
croscopy. CD8-C could not be detected by immuno-electron 
microscopy for reasons that are still unclear. More than 84 % 
of the CD4-C in the Golgi apparatus was present in the TGN 
(Fig. 6) even after 2 h of treatment with cycloheximide (Fig. 
Figure 6. Distribution of TGN38 and hybrid proteins between the 
TGN and Golgi stack at low levels of expression (see Materials and 
Methods) in transiently transfected cells. The number of gold parti- 
cles counted  in each experiment  were 237 (TGN38), 518 (CD4- 
MC), 520  (CD8-MC), 150  (CD4-M), 250  (CDS-M), and 206 
(CD4-C). The distribution shown was very similar to that observed 
at higher levels of expression. 
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and TGN38 in three respects. First, more than 35 % of the 
total protein was present in endosomal structures at low lev- 
els of expression and this increased to nearly 60 % at high 
levels. Second, the type of endosomal structure labeled also 
changed. At low levels, all of the endosomal structures were 
multivesicular bodies which are late endosomal compart- 
ments (Geuze et al.,  1988; Hopkins et al.,  1990). At high 
levels of expression, labeling was also present in tubular en- 
dosomes.  Because of the difficulties of distinguishing be- 
tween tubular endosomes and the TGN (Geuze et al., 1988; 
Klumperman et al.,  1993), definitive identification of these 
structures will have to await further analysis using stably 
transfected cell lines. Third and last, the plasma membrane 
was labeled at both high and low levels of expression (Table 
I). The linear density was the same (0.08  +  0.05 gold parti- 
cles/#m) suggesting that CD4-C was as efficiently removed 
from the cell surface and delivered to endosomes. The pro- 
tein was still concentrated in the TGN since the linear density 
was 9-24 times higher than that in the plasma membrane 
(Table I). 
As a final control, CD4 was also expressed transiently in 
HeLa cells. All of the protein was found in endosomes and 
on the plasma membrane after treatment with cycloheximide 
and  in  agreement  with  studies  carried  out  by  Pelchen- 
Matthews et al. (1991).  Little if any was found in the TGN 
(data not shown). This shows that accumulation of  the hybrid 
proteins in the TGN was not a consequence of the CD4 ec- 
todomain. 
Cell Surface Analysis of  CD8 Hybrid Proteins 
FACS analysis was used to determine the amount of  CD8 and 
CD8  hybrid  proteins  on  the  cell  surface.  Fixed,  non- 
permeabilized cells transfected with the appropriate eDNA 
were stained with the OKT8 antibody to CD8 and visualized 
using a  secondary antibody conjugated to FITC (Fig.  7). 
Mock-transfected cells were used as the negative control and 
the gate was set such that 1% of these cells scored positive. 
The profile of CD8 expression was characteristic of that 
in a population of  transiently transfected cells (Nilsson et al., 
1989; Jackson et al.,  1990) and 58% scored positive (Fig. 
7 A, Table 1I). When both localization signals were present 
(CDS-MC)  only 6%  of the cells showed surface staining 
(Fig. 7 B, Table ]I) and this rose to 19% when the cytoplas- 
mic signal was deleted (CD8-MAC) (Fig. 7 D, Table 1I) sug- 
gesting that the membrane-spanning signal alone could re- 
tain the hybrid protein. This was confirmed by expression of 
CD8-M. Only 13% of the cells scored positive (Fig. 7 C, Ta- 
ble II). 
The cytoplasmic signal alone could also retain the hybrid 
protein. Only 11% of  cells expressing CD8-C scored positive 
A~ 
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C~  CDO-M D~]  CD8-MAC 
...... "fib:  .......  I"P 
E ~  CDS-C 
¢¢  .........  ~.  ."::  ....... 
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Figure  7.  Surface expression 
of CD8 and CD8 hybrid pro- 
teins  analyzed  using  FACS 
analysis.  HeLa  cells  were 
fixed and stained with mono- 
clonal antibody to CD8  and 
visualized using a secondary 
antibody conjugated to FITC. 
The  gate  on  the  x-axis 
(fluorescence  units) was  set 
using  mock-transfected cells 
as  a  negative control.  Cells 
scoring  to  the  right  of this 
point were regarded as posi- 
tive  for cell  surface  fluores- 
cence (see Table I1). 
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Expressing  CD8 and CD8 Hybrid Proteins 
Expressed protein  % Positive  cells*  % Relative intensity* 
CD8  58  100 
CDS-MC  6  2 
CDS-MAC  19  11 
CD8-M  13  22 
CDS-C  11  5 
CD8-AC  68  123 
* The gate was set using moek-transfeeted  cells and 1% were  positive. 5,000 
cells were analyzed  in each experiment. 
* The total fluorescence  intensity was calculated by integrating the area un- 
der the positive  cells and expressing the results as a percentage  of the value 
for CD8. 
(Fig. 7 E, Table II). Removal of the tyrosine-based motif in 
this cytoplasmic signal destroyed its ability to retain hybrid 
proteins. More than 67 % of cells expressing CD8-AC scored 
positive (Fig. 7 F,, Table II), slightly higher than the number 
expressing CD8 alone (58%,  Fig.  7 A, Table II). 
The total fluorescence of positive cells for each protein 
was also calculated by integration of the results presented in 
Fig. 7. These calculations, presented in Table II, are in close 
agreement with the percentage of cells scoring positive and 
provide further evidence that both the membrane-spanning 
and cytoplasmic signals  can,  independently,  retain hybrid 
proteins inside the cell. 
These data were also supported by immunofluorescence 
microscopy on non-permeabilized cells (data not  shown). 
There was no surface staining of cells expressing CD8-MC 
or CD8-C. A few of the transfected cells expressing CD8-M 
showed low levels of cell surface staining.  Cells expressing 
CD8-AC  showed  high  levels  of cell  surface  staining,  in 
agreement with the FACS  analysis. 
Metabolic Labeling of Hybrid Proteins 
CD4 contains two N-linked glycosylation sites (Maddon et 
al.,  1985) one of which is completely processed to the com- 
plex bi-antennary sialylated structure.  Terminal sialic acid 
residues are added by ot2,6-sialyltransferase which is located 
in the trans-Golgi cisterna and the TGN (Roth et al.,  1985). 
Neuraminidase cleaves off these sialic acid residues produc- 
ing  a  small mobility  shift on  SDS-PAGE (Nilsson  et al., 
1989; Jackson et al., 1990) that can be used to show that pro- 
teins have reached this part of the Golgi apparatus. 
Cells expressing CIM or CD4 hybrid proteins were la- 
beled with  [35S]methionine/cysteine for 20 min (see Mate- 
rials and Methods) and either lysed immediately or chased 
with  excess  cold  methionine  and  cysteine  for  2  h.  Im- 
munoprecipitates were treated with neuraminidase or mock- 
treated and analyzed by SDS-PAGE (Fig. 8). Newly synthe- 
sized CIM was insensitive to neuraminidase (cf. lanes I  and 
2) but completely sensitive after a 2-h chase (cf. lanes 3 and 
4).  Hybrid CIM proteins containing either the membrane- 
spanning (CIM-M) or cytoplasmic signal (CIM-C) were also 
completely siaiylated after a 2-h chase period (lanes 9-16). 
Figure 8.  Metabolic  labeling 
of CD4 and CD4 hybrid pro- 
reins. Transfected HeLa cells 
were labeled with [35S]methi- 
onine/cysteine for 20 rain and 
chased  for  0  or  2  h.  Im- 
munoprecipitates were mock- 
digested (lanes 1, 3, 5, 7, 9, 11, 
13, and 15) or digested with 
neuraminidase  (lanes 2, 4, 6, 
8, 10, 12, 14, and 16) and ana- 
lyzed  by  SDS-PAGE and 
fluorography.  The molecular 
size of 14C-radioactive mark- 
ers are indicated  on the  left 
hand side of the panels. 
The Journal of Cell Biology, Volume 125, 1994  264 However,  CD4-MC,  which contains both signals,  was  in- 
completely sialylated after the 2-h chase (lanes 7and 8) sug- 
gesting that transport to the trans part of the Golgi apparatus 
was slower.  The reason for this is unclear but was not the 
consequence of using CD4 as the reporter molecule. CD8- 
MC was also incompletely sialylated (data not shown) in 
contrast to hybrid CD8 proteins containing either TGN38 
signal (Fig. 9). 
Metabolic labeling of CD8 hybrid proteins could not be 
used to study arrival in the trans cisterna and the TGN be- 
cause the bound oligosaccharides are all O-linked (Littman 
et al.,  1985).  Sialylation of O-linked oligosaccharides is 
thought to occur in the medial-Golgi cisterna (Locker et al., 
1992).  However, pulse-chase analysis combined with neur- 
aminidase digestion showed that CD8-M and CD8-C hybrid 
proteins had kinetic properties  similar to those for native 
CD8 (Fig. 9). In all cases the half-time for acquisition of ter- 
minal sialic acid residues was between 25-30 min. Taken 
further with the results for the CD4 hybrid proteins, these 
results show that the presence of either signal had little, if 
any,  effect on  synthesis, transport,  and processing of the 
reporter molecules. 
Discussion 
TGN38 was originally identified as a resident of the TGN 
(Luzio et al., 1990) but more recent work has shown that it 
cycles between the TGN and the cell surface (Jones et al., 
1993; Reaves et al., 1993). Movement to the cell surface oc- 
curs via exocytic vesicles (Jones et al., 1993) and is followed 
by retrieval which requires a signal present in the cytoplas- 
mic domain that has been localized to the sequence SDYQRL 
(Bos et al., 1993; Humphrey et ai.,  1993; Wong and Hong, 
1993).  Retrieved TGN38 first moves to the endosomes and 
then to the TGN (Bos et al., 1993; Humphrey et al., 1993). 
Using plasma membrane glycoproteins as reporter mole- 
cules, we have now shown that there is an additional signal 
for localizing the protein to the TGN. This signal is located 
in the membrane-spanning domain. 
Four independent lines of evidence support this conclu- 
sion.  First,  immunofluorescence microscopy showed that 
CD4-M  and  CD8-M  hybrid proteins  localized  to  a jux- 
tanuclear reticulum that could also be stained by antibodies 
to GAIT, a marker for the trans cisterna and TGN (Roth and 
Berger,  1982;  Taatjes  et al.,  1992;  Nilsson et al.,  1993a). 
This staining pattern was not affected by pretreamaent with 
10 #g/ml cycloheximide  for up to 7 h (data not shown) show- 
ing that these hybrid proteins were not simply moving slowly 
along the exocytic pathway. In addition, it is unlikely that a 
cryptic localization signal in the cytoplasmic domain of ei- 
ther CD4 or CD8 was activated as a result of generating hy- 
brid proteins. Both CD8-MAC and CD4-MAC hybrid pro- 
teins which lack most of the cytoplasmic domain (including 
the cytoplasmic signal for TGN38) were also localized to the 
Golgi apparatus. 
Second, quantitative immunoelectron microscopy showed 
that CIM-M had almost the same distribution as TGN38 at 
both high and low levels of expression. At low levels of ex- 
pression, all of the CD4-M hybrid protein and TGN38 was 
present in the Golgi apparatus, 80% being present within the 
TGN. At higher levels of expression, CIM-M and TGN38 
were also present in endosomes and on the cell surface, again 
to a similar extent. Even at these higher levels of  expression, 
both proteins were still concentrated in the TGN as com- 
pared to the plasma membrane. For TGN38,  the linear den- 
sity in the TGN was four times that in the plasma membrane; 
for CD4-M  it was even higher,  being  12 times higher in 
the TGN than in the plasma membrane. The distribution of 
CD8-M was also similar to that for TGN38 being exclusively 
in the Golgi apparatus at low levels of  expression. There was, 
however,  more of this hybrid protein in the Golgi stack for 
reasons that are still unclear. 
Third, FACS analysis showed that the membrane-spanning 
domain reduced the percentage of positive cells from 58 % 
Figure  9.  Metabolic labeling 
of CD8 and CD8 hybrid pro- 
teins. Transfected HeLa ceils 
were labeled with [35S]methi- 
onine/cysteine  for 20 min and 
chased for0, 15, 30, 45, 75, or 
120 min. Immunoprecipitates 
were mock-digested (-)  or 
digested (+) with neurarnini- 
dase  and  analyzed by  SDS- 
PAGE and fluorography. 
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effect was not the consequence of activating a cryptic signal 
in the cytoplasmic domain of CD8 since removal of most of 
this domain (including the TGN38 cytoplasmic signal) still 
reduced the percentage of positive ceils to 19%  (for CD8- 
MAC), a threefold decrease. 
Fourth and finally, metabolic labeling studies showed that 
all molecules of CD4-M received sialic acid, showing that 
they had all reached the trans cisterna/TGN. 
The present studies are at variance with previous studies 
that identified only the cytoplasmic domain of TGN38 as a 
localiTation signal. Removal of most of the domain led to the 
appearance of the truncated protein on the cell surface (Lu- 
zio et al.,  1990;  Bos et al.,  1993).  It should be noted that 
the earher study was carried out before any evidence existed 
for retention by membrane-spanning domains, a phenome- 
non first described for a viral protein (Swift and Machamer, 
1991)  and Golgi enzymes (Nilsson et al.,  1991; Munro, 
1991). The expectation was that the signal would be found 
in the cytoplasmic domain and this appeared to be borne out 
by the appearance of protein on the cell surface. The likely 
reason for this, however, was that the levels of expressed pro- 
tein were so high that they saturated the retention mechanism 
that operates on the membrane-spanning domain. Even cells 
expressing the wild-type protein (TGN38), containing both 
retention and retrieval signals, showed aberrant localization. 
After 24 h transfection, 50% of the cells had either fallen off 
the coverslip or showed cell surface staining (Luzio et al., 
1990).  The more recent study by Bos et al. (1993) overcame 
this problem by using a similar expression vector (pSVL1) 
at a  low transfection efficiency (~0.15%)  to ensure more 
constant levels of expression in each cell.  Unfortunately, 
their only assay was immunofluorescence microscopy and it 
was impossible to determine how much of the protein was 
still present in the Golgi apparatus. These problems did not 
arise in our system since the expressed levels of hybrid pro- 
tein were lower and the distributions were quantitated in sev- 
eral  independent ways.  Two different reporter  molecules 
were also used. However,  it is conceivable that other small 
differences in the systems used are responsible for the appar- 
ent discrepancies.  Wong and Hong  (1993),  for example, 
found that the serine residue in the SDYQRL motif was im- 
portant for Golgi localization, while Humphrey et al. (1993) 
found that an identical mutation in their system had no effect. 
Further studies using stable cell lines will be needed to re- 
solve these differences. 
Though the cytoplasmic and membrane-spanning signals 
can  act  independently to  localize hybrid proteins  to  the 
TGN, it is likely that they operate in different  ways. The cyto- 
plasmic domain is a clear example of a retrieval signal. This 
acts after a protein has left the compartment in which it nor- 
really functions and returns them from a later compartment. 
All of the retrieval signals so far characterized have been lo- 
cated in the cytoplasmic domains of proteins and many are 
based on tyrosine as the critical amino acid set in a particular 
motif (for  review  see  Collawn et  al.,  1990;  Pearse  and 
Robinson, 1990; Kornfeld, 1992; Matter et ai., 1992).  The 
critical  motif in  the  cytoplasmic  domain  of TGN38  is 
SDYQRL (Bos et al.,  1993;  Humphrey et al., 1993; Wong 
and Hong, 1993) and it operates once the protein reaches the 
cell surface. TGN38 is then returned to the TGN via endo- 
somes. 
The membrane-spanning domain is a typical Golgi reten- 
tion signal. These act to keep proteins in the Golgi and, so 
far, all Golgi proteins (Machamer and Swift, 1991) and en- 
zymes (Nilsson et al., 1991; Munro, 1991; Aoki et al., 1992; 
Burke et al.,  1992;  Colley et al.,  1992;  Tang et ai.,  1992; 
Teasdale et al.,  1992;  Wong et al.,  1992) have been found 
to  be  retained  by  the  membrane-spanning  domain.  The 
mechanism of retention is still unclear though two possibili- 
ties have been proposed. TGN38 molecules could interact 
with their neighbors through the spanning domains forming 
kin oligomers so large that they can no longer enter vesicles 
budding  from the  TGN  (Nilsson  et al.,  1994).  Alterna- 
tively, the length of the membrane-spanning domain might 
prevent  forward movement of the  protein  past  the  TGN 
(Bretscher and Munro,  1993).  The latter seems less likely 
since  the  length  of the  membrane-spanning  domain  (19 
amino acids) is longer than the estimated average for Golgi 
proteins (15 amino acids) but further work will be needed to 
determine whether either of these mechanisms, or a com- 
pletely different one,  are  responsible for retention in the 
TGN. 
Our results suggest that the membrane-spanning domain 
is an effective retention signal since alone it can confer local- 
ization properties on CD4 that make it virtually indistin- 
guishable from TGN38.  The predicted effect of its absence 
would be an increased flux of protein through the TGN to 
the cell surface. In other words, its absence should put a 
greatly increased load on to the retrieval system. As fast as 
the protein is retrieved and returned to the TGN, it would es- 
cape to the plasma membrane and need to be retrieved again. 
This would explain why CD4-C, which has the retrieval but 
not the retention signal, is present in both endosomes and at 
the plasma membrane even at low levels of expression. The 
rate-limiting step in retrieval is not endocytosis because the 
linear density of CD4-C at the plasma membrane was the 
same at both low and high levels of expression. The limiting 
step must be between endosomes and the TGN since CD4-C 
accumulates in endosomes as the expression level increases. 
The only result that is a little puzzling is the presence of 
CD4-M in endosomes at high expression levels. This hybrid 
protein would be expected to leak very slowly to the cell sur- 
face, but, in the absence of a retrieval signal, it should ac- 
cumulate there. One possibility is that the endocytic signal 
in the CD4 cytoplasmic domain (Shin et al., 1991) triggers 
movement to endosomes; another possibility is that the pro- 
tein in the endosome is destined for degradation in lyso- 
somes.  This latter possibility is  more likely for CDS-M 
which lacks an endocytic signal yet is found in small amounts 
in what appear to be endosomes by immunofluorescence  mi- 
croscopy. 
It is likely that other proteins on the exocytic pathway have 
both retention and retrieval signals.  The sum of the two 
processes  acting  on  these  signals  would  determine  the 
amount of protein found in a particular compartment. For 
resident proteins which should spend as much of their time 
as possible in a particular compartment one would expect 
retention rather than retrieval to be the dominant process. 
For recycling proteins, such as receptors, one would expect 
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moving  between  two  compartments.  It  is  not  yet  clear 
whether TGN38 is best considered as a resident or a recy- 
cling protein (Luzio and Banting, 1993; Stanley and Howell, 
1993).  That will have to await discovery of its function. 
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